Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
  • LinkedIn
  • Instagram
OtherPractice

Answer: Can you identify this condition?

Marisa G. Ponzo and Eiman Nasseri
Canadian Family Physician December 2012; 58 (12) 1364-1365;
Marisa G. Ponzo
Dermatology resident at the University of British Columbia in Vancouver.
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eiman Nasseri
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

Answer to Dermacasecontinued frompage 1361

5. Speckled lentiginous nevus

A speckled lentiginous nevus (SLN), or nevus spilus (from the Greek word spilos, meaning spot), clinically appears as a hyperpigmented macule or patch containing scattered, dark, macular or papular foci. Speckled lentiginous nevi are identified in less than 0.2% of neonates,1 1% to 2% of white schoolchildren,2 and 2% to 3% of white adults,3,4 although no data are available on the prevalence in individuals with darker skin. There is no sex predilection, although there is a distribution predilection for the trunk and lower limbs.4

Speckled lentiginous nevi can be congenital or acquired lesions, and the distinction is based on patient history and histology. A congenital SLN is present at birth or soon after, might have segmental or zosteriform patterns of distribution reflecting embryonic development, and shows histologic features consistent with a congenital skin lesion.5 Speckled lentiginous nevi can be overlooked at birth owing to their light coloration, and might become more obvious and deeply pigmented months to years later, making it difficult to distinguish congenital from acquired lesions based on history alone. In the case described above, the SLN was indeed present since birth and showed histologic features consistent with a congenital skin lesion.

Diagnosis

Clinical appearance and patient history typically provide sufficient information to make the diagnosis of SLN. Clinically, an SLN appears as an evenly hyperpigmented macule or patch containing dark, scattered foci. The background macule or patch can range in size from less than 1 cm to greater than 10 cm.6 A Wood lamp might be needed to visualize the background patch if it is weakly pigmented. The differential diagnosis of SLN includes nevomelanocytic nevus, lentigo, café au lait spot, and malignant melanoma.

Human skin is made up of several types of cells, including melanocytes, which contain melanin pigment and account for the colour of skin. In normal skin, single melanocytes are mainly found interspersed among other cells along the epidermal basement membrane, and less commonly within the dermis and upper epidermis. A nevomelanocytic nevus, also known as a common mole, appears clinically as a small, round, uniform, pink to dark-brown macule, papule, or plaque. Histologically, melanocytes are in small, circumscribed, organized nests within the epidermis (junctional nevomelanocytic nevus), dermis (intradermal nevomelanocytic nevus), or both (compound nevomelanocytic nevus). They typically appear in childhood or young adulthood and are more frequent in the second and third decades of life, appearing commonly on sun-exposed areas of skin.7

Lentigines are formed by an increased number of neighbouring melanocytes at the epidermal basement membrane that do not form nests. They can be congenital or acquired lesions that typically appear as sharply circumscribed, light-brown or dark-brown macules, otherwise known as freckles. Macules can be isolated or aggregated (present as a cluster of macules), and can be found on the skin, nails, and mucus membranes. Aggregated lentigines can mimic the appearance of an SLN. A Wood lamp can be useful in determining the existence of a background hyperpigmented patch, which is typical of an SLN but not of aggregated lentigines.8

Café au lait spots are formed by a normal number of melanocytes in the skin that contain increased amounts of melanin pigment. Clinically, they are flat, sharply circumscribed, and evenly coloured light-brown macules or patches without the dark foci that are typically seen in SLN. They are frequently present at birth, become more numerous as the child grows, and tend to grow in proportion to the overall growth of the child. The presence of numerous café au lait spots can be a marker for certain syndromes such as neurofibromatosis type 1.9

Malignant melanoma describes the aberrant proliferation of single melanocytes from within a nevus or from solitary cells within the skin. Several clinical and histologic subtypes of melanoma exist, although they are rare in childhood and adolescence. It can be clinically difficult to distinguish a benign nevomelanocytic nevus from an early melanoma. Clinical suspicion of melanoma is raised with a new lesion, a change in size of an existing lesion, the presence of nonuniform features such as a variation or change in colour, asymmetry, or border irregularity.10

Evolution

An SLN can evolve over the lifetime of the individual. Specifically, new hyperpigmented elements within the background macule or patch might appear, or existing elements might evolve over time. If an element appears nonuniform, appears unusual compared with the others, or changes over time, the development of an early melanoma should be ruled out.

The absolute risk of developing a malignant melanoma from an SLN is poorly defined. In an early study, Kopf et al identified nevi spili in 4.8% of a cohort of 105 white adults with melanoma compared with 2.3% of a cohort of 601 melanoma-free adults; however, this difference was not statistically significant.11 Nevertheless, numerous case reports have described the development of malignant melanoma from SLN.12–19 A systematic review including 14 studies and 6571 patients with congenital melanocytic nevi reported that the overall risk of developing malignant melanoma was 0.7%.20 Further, the risk of developing melanoma and the rate of a fatal course increased for larger congenital melanocytic nevi (> 40 cm in diameter).20 Other smaller studies have reported an incidence of melanoma of about 1% to 2%.21,22 Larger studies with long-term follow-up are necessary to calculate the absolute risk of melanoma development from SLN, although it is likely small.

Management

Patients with speckled lentiginous nevi should be informed that, as with most melanocytic lesions, there is a small lifetime risk of malignancy. For this reason, their lesions should be assessed by physicians annually.17 Dermoscopy is a noninvasive method of screening for atypical changes in the hyperpigmented foci within the background macule or patch of the SLN. Photographic documentation can be used to monitor changes in the SLN over time. Biopsy should be reserved for lesions in which there is suspicion of malignancy, such as those with atypical elements including changes in size and colour, border irregularities, or growth of an element within the SLN.23 When in doubt, referral to a dermatologist is warranted.

Footnotes

  • Competing interests

    None declared

  • Copyright© the College of Family Physicians of Canada

References

  1. ↵
    1. Walton RG,
    2. Jacobs AH,
    3. Cox AJ
    . Pigmented lesions in newborn infants. Br J Dermatol 1976;95(4):389-96.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Sigg C,
    2. Pelloni F,
    3. Schnyder UW
    . Frequency of congenital nevi, nevi spili and café-au-lait spots and their relation to nevus count and skin complexion in 939 children. Dermatologica 1990;180(3):118-23.
    OpenUrlPubMed
  3. ↵
    1. Menon K,
    2. Dusza SW,
    3. Marghoob AA,
    4. Halpern AC,
    5. Nehal KS
    . Classification and prevalence of pigmented lesions in patients with total-body photographs at high risk of developing melanoma. J Cutan Med Surg 2006;10(2):85-91.
    OpenUrlPubMed
  4. ↵
    1. Kopf AW,
    2. Levine LJ,
    3. Rigel DS,
    4. Friedman RJ,
    5. Levenstein M
    . Prevalence of congenital-nevus-like nevi, nevi spili, and café au lait spots. Arch Dermatol 1985;121(6):766-9.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Schaffer JV,
    2. Orlow SJ,
    3. Lazova R,
    4. Bolognia JL
    . Speckled lentiginous nevus: within the spectrum of congenital melanocytic nevi. Arch Dermatol 2001;137(2):172-8.
    OpenUrlPubMed
  6. ↵
    1. Cohen HJ,
    2. Minkin W,
    3. Frank SB
    . Nevus spilus. Arch Dermatol 1970;102(4):433-7.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Gellin GA,
    2. Kopf AW,
    3. Garfinkel L
    . Malignant melanoma. A controlled study of possibly associated factors. Arch Dermatol 1969;99(1):43-8.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Paraskevas LR,
    2. Halpern AC,
    3. Marghoob AA
    . Utility of the Wood’s light: five cases from a pigmented lesion clinic. Br J Dermatol 2005;152(5):1039-44.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Boyd KP,
    2. Korf BR,
    3. Theos A
    . Neurofibromatosis type 1. J Am Acad Dermatol 2009;61(1):1-14.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Ricotti C,
    2. Bouzari N,
    3. Agadi A,
    4. Cockerell CJ
    . Malignant skin neoplasms. Med Clin North Am 2009;93(6):1241-64.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Kopf AW,
    2. Levine LJ,
    3. Rigel DS,
    4. Friedman RJ,
    5. Levenstein M
    . Congenital-nevus-like nevi, nevi spili, and café-au-lait spots in patients with malignant melanoma. J Dermatol Surg Oncol 1985;11(3):275-80.
    OpenUrlPubMed
  12. ↵
    1. Kurban RS,
    2. Preffer FI,
    3. Sober AJ,
    4. Mihm MC Jr.,
    5. Barnhill RL
    . Occurrence of melanoma in “dysplastic” nevus spilus: report of case and analysis by flow cytometry. J Cutan Pathol 1992;19(5):423-8.
    OpenUrlPubMed
    1. Grinspan D,
    2. Casala A,
    3. Abulafia J,
    4. Mascotto J,
    5. Allevato M
    . Melanoma on dysplastic nevus spilus. Int J Dermatol 1997;36(7):499-502.
    OpenUrlPubMed
    1. Borrego L,
    2. Hernandez Santana J,
    3. Baez O,
    4. Hernandez Hernandez B
    . Naevus spilus as a precursor of cutaneous melanoma: report of a case and literature review. Clin Exp Dermatol 1994;19(6):515-7.
    OpenUrlCrossRefPubMed
    1. Weinberg JM,
    2. Schutzer PJ,
    3. Harris RM,
    4. Tangoren IA,
    5. Sood S,
    6. Rudolph RI
    . Melanoma arising in nevus spilus. Cutis 1998;61(5):287-9.
    OpenUrlPubMed
    1. Vázquez-Doval J,
    2. Sola MA,
    3. Contreras-Mejuto F,
    4. Redondo P,
    5. Soto J,
    6. Quintanilla E
    . Malignant melanoma developing in a speckled lentiginous nevus. Int J Dermatol 1995;34(9):637-8.
    OpenUrlPubMed
  13. ↵
    1. Meguerditchian AN,
    2. Cheney RT,
    3. Kane JM 3rd.
    . Nevus spilus with synchronous melanomas: case report and literature review. J Cutan Med Surg 2009;13(2):96-101.
    OpenUrlPubMed
    1. Abecassis S,
    2. Spatz A,
    3. Cazeneuve C,
    4. Martin-Villepou A,
    5. Clerici T,
    6. Lacour JP,
    7. et al
    . Melanoma within naevus spilus: 5 cases [article in French]. Ann Dermatol Venereol 2006;133(4):323-8.
    OpenUrlPubMed
  14. ↵
    1. Haenssle HA,
    2. Kaune KM,
    3. Buhl T,
    4. Thoms KM,
    5. Padeken M,
    6. Emmert S,
    7. et al
    . Melanoma arising in segmental nevus spilus: detection by sequential digital dermatoscopy. J Am Acad Dermatol 2009;61(2):337-41. Epub 2009 Feb 23.
    OpenUrlPubMed
  15. ↵
    1. Krengel S,
    2. Hauschild A,
    3. Schafer T
    . Melanoma risk in congenital melanocytic naevi: a systematic review. Br J Dermatol 2006;155(1):1-8.
    OpenUrlPubMed
  16. ↵
    1. Bett BJ
    . Large or multiple congenital melanocytic nevi: occurrence of cutaneous melanoma in 1008 persons. J Am Acad Dermatol 2005;52(5):793-7.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Hale EK,
    2. Stein J,
    3. Ben-Porat L,
    4. Panageas KS,
    5. Eichenbaum MS,
    6. Marghoob AA,
    7. et al
    . Association of melanoma and neurocutaneous melanocytosis with large congenital melanocytic naevi—results from the NYU-LCMN registry. Br J Dermatol 2005;152(3):512-7.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Kinsler VA,
    2. Chong WK,
    3. Aylett SE,
    4. Atherton DJ
    . Complications of congenital melanocytic naevi in children: analysis of 16 years’ experience and clinical practice. Br J Dermatol 2008;159(4):907-14. Epub 2008 Jul 30.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Canadian Family Physician: 58 (12)
Canadian Family Physician
Vol. 58, Issue 12
1 Dec 2012
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Answer: Can you identify this condition?
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Answer: Can you identify this condition?
Marisa G. Ponzo, Eiman Nasseri
Canadian Family Physician Dec 2012, 58 (12) 1364-1365;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Answer: Can you identify this condition?
Marisa G. Ponzo, Eiman Nasseri
Canadian Family Physician Dec 2012, 58 (12) 1364-1365;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • 5. Speckled lentiginous nevus
    • Diagnosis
    • Evolution
    • Management
    • Footnotes
    • References
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • Question: Can you identify this condition?
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Practice

  • Managing type 2 diabetes in primary care during COVID-19
  • Effectiveness of dermoscopy in skin cancer diagnosis
  • Spontaneous pneumothorax in children
Show more Practice

Dermacase

  • Question: Can you identify this condition?
  • Answer: Can you identify this condition?
  • Question: Can you identify this condition?
Show more Dermacase

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • LinkedIn
  • Instagram
  • RSS Feeds

Copyright © 2025 by The College of Family Physicians of Canada

Powered by HighWire